From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: ouzo after 12 years from Warwick and after almost as long from Advanced Oncotherapy

By Tom Winnifrith | Friday 30 June 2023


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


After 12 years of campaigning, a result from Warwick School last night as reported HERE but now another victim of sexual abuse has been in touch so I guess the campaigning goes on. I am almost certain that I will name a paedophile teacher tomorrow. Then more, after I exposed it in almost 300 articles, ouzo c/o Advanced Oncotherapy (AVO) which looks to be, effectively, brown bread. I look at looming share suspensions including Premier African (PREM), Boohoo (BOO) and Revolution Beauty (REVB), the fraud Supply@ME Captal (SYME) and Cellular Goods (CBX), also on deadline day.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 18:03:53